source
- Biossil Labs acquires Theriva's antibiotic-degrader portfolio in up to $91 million dealBiossil Labs, a Canadian biotech backed by OpenAI, announced a deal to acquire Theriva Biologics' early- to mid-stage portfolio of antibiotic‑degrading enzymes for a total potential value of up to…
- Women travel abroad for unproven three-parent IVF marketed to older patientsSTAT investigators found that women are journeying thousands of miles to undergo a mitochondrial‑replacement IVF procedure that is promoted as a fertility option for older patients, even though the…